Follicular-fluid anti-Mullerian hormone concentrations are predictive of assisted reproduction outcome in PCOS patients

Reproductive BioMedicine Online

Volumn 19, Issue 5, 2009, Pages 631-637

  Pabuccu, Recai ^a   Kaya, Cemil ^a   Caǧlar, Gamze Sinem ^a   Oztas, Efser ^a   Satiroglu, Hakan ^b  

^a UFUK UNIVERSITY   (Turkey)

^b ANKARA UNIVERSITY   (Turkey)

Author keywords

AMH; Assisted reproduction cycles; Follicular fluid; PCOS

Indexed keywords

ESTRADIOL; MUELLERIAN INHIBITING FACTOR;

ADULT; ARTICLE; CONTROLLED STUDY; EMBRYO; FEMALE; FERTILIZATION; FERTILIZATION IN VITRO; HUMAN; INTRACYTOPLASMIC SPERM INJECTION; MAJOR CLINICAL STUDY; NIDATION; OOCYTE; OOCYTE RETRIEVAL; OVARY FOLLICLE FLUID; OVARY POLYCYSTIC DISEASE;

EID: 74949104934     PISSN: 14726483     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rbmo.2009.06.010     Document Type: Article

References (39)

1. Balen AH, Laven JS, Tan SL, Dewailly D 2003 Ultrasound assessment of the polycystic ovary: international consensus definitions. Human Reproduction Update 9, 505-14.
2. Cano F, Garcia-Velasco JA, Millet A et al. 1997 Oocyte quality in polycystic ovaries revisited: identification of a particular subgroup of women. Journal of Assisted Reproduction and Genetics 14, 254-261.
3. Chang MY, Chiang CH, Hsieh TT et al. 1998 Use of the antral follicle count to predict the outcome of assisted reproductive technologies. Fertility and Sterility 69, 505-510.
4. Cook CL, Siow Y, Brenner AG, Fallat ME 2002 Relationship between serum Müllerian-inhibiting substance and other reproductive hormones in untreated women with polycystic ovary syndrome and normal women. Fertility and Sterility 77, 141-146.
5. Das M, Gillott DJ, Saridogan E, Djahanbakhch O 2008 Antimullerian hormone is increased in follicular fluid from stimulated ovaries in women with polycystic ovary syndrome. Human Reproduction 23, 2122-2126.
6. Di Clemente N, Goxe B, Remy JJ et al. 1994 Inhibitory effect of anti-mullerian hormone upon aromatase activity and LH receptors of granulosa cells of rat and porcine immature ovaries. Endocrine 2, 553-558.
7. Dor J, Ben-Shlomo I, Levran D et al. 1992 The relative success of gonadotropin-releasing hormone analogue, clomiphene citrate, and gonadotropin in 1,099 cycles of in-vitro fertilisation. Fertility and Sterility 58, 986-990.
8. Durlinger AL, Gruijters MJ, Kramer P et al. 2001 Anti-mullerian hormone attenuates the effects of FSH on follicle development in the Mouse ovary. Endocrinology 142, 4891-4899.
9. Ebner T, Sommergruber M, Moser M et al. 2006 Basal level of anti-Müllerian hormone is associated with oocyte quality in stimulated cycles. Human Reproduction 21, 2022-2026.
10. Eldar-Geva T, Ben-Chetrit A, Spitz IM et al. 2005 Dynamic assays of inhibin B, anti-mullerian hormone and estradiol following FSH stimulation and ovarian ultrasonography as predictors of IVF outcome. Human Reproduction 20, 3178-3183.
11. Fallat ME, Siow Y, Marra M et al. 1997 Müllerian-inhibiting substance in follicular fluid and serum: a comparison of patients with tubal factor infertility, polycystic ovary syndrome, and endometriosis. Fertility and Sterility 67, 962-965.
12. Fanchin R, Lozano DHM, Frydman N et al. 2007 Anti-Müllerian hormone concentrations in the follicular fluid of the preovulatory follicle are predictive of the implantation potential of the ensuing embryo obtained by in-vitro fertilization. Journal of Clinical Endocrinology and Metabolism 92, 1796-1802.
13. Franks S, Roberts R, Hardy K 2002 Gonadotrophin regimens and oocyte quality in women with polycystic ovary syndrome. Reproductive BioMedicine Online 6, 181-184.
14. Franks S 1995 Polycystic ovary syndrome. New England Journal of Medicine 333, 853-861.
15. Guzick DS, Overstreet JW, Factor-Litvak P et al. 2001 Sperm morphology, motility, and concentration in fertile and infertile men. New England Journal of Medicine 345, 1388-1393.
16. Hazout A, Bouchard P, Seifer DB et al. 2004 Serum antiMullerian hormone/mullerian-inhibiting substance appears to be a more discriminatory marker of assisted reproductive technology outcome than follicle-stimulating hormone, inhibin B, or estradiol. Fertility and Sterility 82, 1323-1329.
17. Kruger TF, Acosta AA, Simmons KF et al. 1988 Predictive value of abnormal sperm morphology in in-vitro fertilization. Fertility and Sterility 49, 112-117.
18. La Marca A, Malmusi S, Giulini S et al. 2004 Anti-Müllerian hormone plasma levels in spontaneous menstrual cycle and during treatment with FSH to induce ovulation. Human Reproduction 19, 27382741.
19. Laszlo FJMM, Banchsi LF, Broekmans FJ et al. 2002 Predictors of poor ovarian response in in-vitro fertilization: a prospective study comparing basal markers of ovarian reserve. Fertility and Sterility 77, 328-336.
20. Lekamge DN 2007 Anti-Müllerian hormone as a predictor of IVF outcome. Reproductive BioMedicine Online 14, 602-610.
21. Laven JS, Mulders AG, Visser JA et al. 2004 Anti-Mullerian hormone serum concentration in nornoovulatory and anovulatory women of reproductive age. Journal of Clinical Endocrinology and Metabolism 89, 318-323.
22. Ludwig M, Finas DF, Al-Hasani S et al. 1999 Oocyte quality and treatment outcome in intracytoplasmic sperm injection cycles of polycystic ovarian syndrome patients. Human Reproduction 14, 354-358.
23. Mulders A 2003 IVF outcome in anovulatory infertility (WHO-group 2)-including polycystic ovary syndrome-following previous unsuccessful ovulation induction. Reproductive BioMedicine Online 7, 50-58.
24. Paulson RJ, Suaer MV, Lobo RA 1990 Embryo implantation after human in-vitro fertilization: importance of endometrial receptivity. Fertility and Sterility 53, 870-874.
25. Pellicer A, Valbuena D, Cano F et al. 1996 Lower implantation rates in high responders (evidence for an altered endocrine milieu during the preimplantation period). Fertility and Sterility 65, 1190-1195.
26. Pigny P, Cortet-Rudelli C, Decanter C et al. 2003 Elevated serum level of anti-mullerian hormone in patients with polycystic ovary syndrome: relationship to the ovarian follicle excess and to the follicular arrest. Journal of Clinical Endocrinology and Metabolism 88, 5957-5962.
27. Plachot M, Belaisch-Allart J, Mayenga JM et al. 2003 Oocyte and embryo quality in polycystic ovary syndrome. Gynécologie, obstétrique and fertilité 31, 350-354.
28. Reuss ML, Kline J, Santos R et al. 1996 Age and the ovarian follicle pool assessed with transvaginal ultrasonography. American Journal of Obstetrics and Gynecology 174, 624-627.
29. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group 2004 Revised 2003 consensus on diagnostic criteria and long-term healthy risks related to polycystic ovary syndrome. Fertility and Sterility 81, 19-25.
30. Silberstein T, Maclaughin DT, Shai I et al. 2006 Mullerian inhibiting substance levels at the time of HCG administration in IVF cycles predict both ovarian reserve and embryo morphology. Human Reproduction 21, 159-163.
31. Stubbs SA, Hardy K, Silva-Buttkus PD et al. 2005 Anti-Mullerian hormone protein expression is reduced during development the initial stages of follicle development in human polycystic ovaries. Journal of Clinical Endocrinology and Metabolism 90, 5536-5543.
32. Takahashi C, Fujito A, Kazuka M et al. 2008 Anti-Müllerian hormone substance from follicular fluid is positively associated with success in oocyte fertilization during in-vitro fertilization. Fertility and Sterility 89, 586-591.
33. Teissier M, Chable H, Paulhac S, Aubard Y 2000 Comparison of follicle steroidogenesis from normal and polycystic ovaries in women undergoing IVF: relationship between steroid concentrations, follicle size, oocyte quality and fecundability. Human Reproduction 15, 2471-2477.
34. Tesarik J, Junca AM, Hazout A et al. 2000 Embryos with high implantation potential after intracytoplasmic sperm injection can be recognized by a simple, non-invasive examination of pronuclear morphology. Human Reproduction 15, 1396-1399.
35. Valbuena D, Martin J, Pablo JL et al. 2001 Increasing levels of estradiol are deleterious to embryonic implantation because they directly affect the embryo. Fertility and Sterility 76, 962-968.
36. van der Meer M, Hompes PGA, de Boer JAM et al. 1998 Cohort size rather than follicle-stimulating hormone threshold level determines ovarian sensitivity in polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism 83, 423-426.
37. Webber LJ, Stubbs S, Stark J et al. 2003 Formation and early development of follicles in the polycystic ovary. Lancet 362, 1017-1021.
38. Weenen C, Laven JS, Von Bergh AR et al. 2004 Anti-mullerian hormone expression pattern in the human ovary: potential implications for initial and cyclic follicle recruitment. Molecular Human Reproduction 10, 77-83.
39. World Health Organization 1999 Laboratory Manual for the Examination of Human Semen and Sperm-Cervical Mucus Interaction 4th edn. Cambridge University Press, Cambridge.